 Gabriela Garcia
Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Uric Acid | 10 | 2021 | 150 | 0.900 |
Why?
| | Kidney Diseases | 3 | 2021 | 355 | 0.740 |
Why?
| | Glomerulonephritis | 2 | 2020 | 45 | 0.670 |
Why?
| | Renal Insufficiency, Chronic | 6 | 2021 | 488 | 0.660 |
Why?
| | Fructokinases | 5 | 2016 | 29 | 0.610 |
Why?
| | Glomerular Basement Membrane | 2 | 2020 | 7 | 0.560 |
Why?
| | Fructose | 6 | 2018 | 100 | 0.560 |
Why?
| | Kidney | 6 | 2021 | 1208 | 0.500 |
Why?
| | alpha7 Nicotinic Acetylcholine Receptor | 1 | 2015 | 97 | 0.490 |
Why?
| | Hyperuricemia | 3 | 2021 | 43 | 0.490 |
Why?
| | Protein Subunits | 1 | 2015 | 205 | 0.470 |
Why?
| | Fibrosis | 1 | 2015 | 455 | 0.430 |
Why?
| | AMP Deaminase | 3 | 2015 | 9 | 0.350 |
Why?
| | Podocytes | 2 | 2020 | 44 | 0.330 |
Why?
| | Fatty Liver | 3 | 2018 | 217 | 0.310 |
Why?
| | Inflammation | 1 | 2015 | 2503 | 0.240 |
Why?
| | Metabolic Syndrome | 2 | 2018 | 323 | 0.200 |
Why?
| | Peptidyl-Dipeptidase A | 1 | 2021 | 53 | 0.190 |
Why?
| | Hypertension | 3 | 2017 | 1063 | 0.190 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2021 | 78 | 0.190 |
Why?
| | Renin-Angiotensin System | 1 | 2021 | 72 | 0.190 |
Why?
| | Japan | 5 | 2017 | 89 | 0.180 |
Why?
| | Receptors, Fc | 1 | 2020 | 45 | 0.180 |
Why?
| | Glomerular Filtration Rate | 3 | 2021 | 605 | 0.180 |
Why?
| | Dehydration | 2 | 2019 | 38 | 0.180 |
Why?
| | Kidney Glomerulus | 2 | 2018 | 102 | 0.180 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2020 | 173 | 0.170 |
Why?
| | Gene Expression Regulation | 3 | 2018 | 2362 | 0.170 |
Why?
| | Diabetes Mellitus | 2 | 2017 | 906 | 0.170 |
Why?
| | Heat Stress Disorders | 1 | 2019 | 39 | 0.160 |
Why?
| | Heat-Shock Response | 1 | 2018 | 46 | 0.160 |
Why?
| | Kidney Calculi | 1 | 2018 | 30 | 0.160 |
Why?
| | B7-1 Antigen | 1 | 2018 | 54 | 0.160 |
Why?
| | Proteinuria | 1 | 2018 | 78 | 0.150 |
Why?
| | Obesity, Metabolically Benign | 1 | 2017 | 4 | 0.150 |
Why?
| | Prehypertension | 1 | 2017 | 24 | 0.150 |
Why?
| | Mice, Inbred C57BL | 6 | 2019 | 4769 | 0.150 |
Why?
| | Urinary Calculi | 1 | 2017 | 11 | 0.140 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2015 | 175 | 0.140 |
Why?
| | Asymptomatic Diseases | 1 | 2017 | 77 | 0.140 |
Why?
| | Vasopressins | 1 | 2016 | 57 | 0.140 |
Why?
| | Energy Metabolism | 2 | 2019 | 712 | 0.140 |
Why?
| | Diabetes Mellitus, Experimental | 2 | 2014 | 161 | 0.130 |
Why?
| | Sodium | 1 | 2017 | 182 | 0.130 |
Why?
| | Hypothalamus | 1 | 2016 | 150 | 0.130 |
Why?
| | Albuminuria | 1 | 2016 | 164 | 0.130 |
Why?
| | Tissue Inhibitor of Metalloproteinase-3 | 1 | 2015 | 7 | 0.130 |
Why?
| | Tissue Inhibitor of Metalloproteinase-2 | 1 | 2015 | 12 | 0.130 |
Why?
| | Dyslipidemias | 1 | 2017 | 155 | 0.130 |
Why?
| | Fibrin | 1 | 2015 | 65 | 0.120 |
Why?
| | Hepatocytes | 2 | 2012 | 197 | 0.120 |
Why?
| | Hibernation | 1 | 2015 | 72 | 0.120 |
Why?
| | Starvation | 1 | 2014 | 21 | 0.120 |
Why?
| | Gluconeogenesis | 1 | 2014 | 60 | 0.120 |
Why?
| | Mitochondria | 1 | 2019 | 753 | 0.110 |
Why?
| | Kidney Tubules, Proximal | 1 | 2014 | 113 | 0.110 |
Why?
| | Animals | 12 | 2020 | 32123 | 0.110 |
Why?
| | Mice, Knockout | 5 | 2020 | 2606 | 0.110 |
Why?
| | Mice | 7 | 2020 | 15075 | 0.110 |
Why?
| | Adenylate Kinase | 1 | 2012 | 27 | 0.110 |
Why?
| | Collagen | 1 | 2015 | 415 | 0.110 |
Why?
| | Transforming Growth Factor beta | 1 | 2015 | 447 | 0.100 |
Why?
| | Kidney Transplantation | 1 | 2018 | 560 | 0.100 |
Why?
| | Liver | 3 | 2015 | 1693 | 0.100 |
Why?
| | Macrophages | 2 | 2015 | 1281 | 0.100 |
Why?
| | Adipose Tissue | 1 | 2015 | 553 | 0.100 |
Why?
| | Diabetic Nephropathies | 1 | 2014 | 234 | 0.100 |
Why?
| | Cytokines | 2 | 2015 | 1857 | 0.090 |
Why?
| | Risk Factors | 6 | 2018 | 8714 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2020 | 3582 | 0.090 |
Why?
| | Obesity | 2 | 2019 | 2530 | 0.090 |
Why?
| | Hep G2 Cells | 3 | 2014 | 61 | 0.080 |
Why?
| | Male | 11 | 2018 | 56128 | 0.080 |
Why?
| | Kidney Function Tests | 2 | 2019 | 141 | 0.080 |
Why?
| | Cohort Studies | 4 | 2018 | 4960 | 0.070 |
Why?
| | Humans | 14 | 2021 | 115908 | 0.070 |
Why?
| | Aging | 1 | 2016 | 1640 | 0.070 |
Why?
| | Hot Temperature | 2 | 2019 | 302 | 0.070 |
Why?
| | Body Mass Index | 3 | 2018 | 1982 | 0.070 |
Why?
| | Cardiovascular Diseases | 1 | 2017 | 1724 | 0.060 |
Why?
| | Middle Aged | 7 | 2018 | 27084 | 0.060 |
Why?
| | Retrospective Studies | 5 | 2018 | 12616 | 0.060 |
Why?
| | Adult | 6 | 2018 | 30820 | 0.050 |
Why?
| | Logistic Models | 2 | 2017 | 1865 | 0.050 |
Why?
| | Sex Factors | 2 | 2017 | 1741 | 0.050 |
Why?
| | Female | 6 | 2018 | 60086 | 0.050 |
Why?
| | Isoenzymes | 2 | 2012 | 286 | 0.050 |
Why?
| | Incidence | 2 | 2017 | 2333 | 0.050 |
Why?
| | Blood Pressure | 2 | 2017 | 1536 | 0.050 |
Why?
| | Oxidation-Reduction | 2 | 2015 | 933 | 0.050 |
Why?
| | Mice, Obese | 1 | 2019 | 52 | 0.040 |
Why?
| | Aged | 4 | 2018 | 19299 | 0.040 |
Why?
| | Calcium Oxalate | 1 | 2018 | 5 | 0.040 |
Why?
| | Kidney Tubules | 1 | 2019 | 107 | 0.040 |
Why?
| | Nephrosis | 1 | 2018 | 4 | 0.040 |
Why?
| | Galactosyltransferases | 1 | 2018 | 11 | 0.040 |
Why?
| | Abatacept | 1 | 2018 | 40 | 0.040 |
Why?
| | Nephrosis, Lipoid | 1 | 2018 | 10 | 0.040 |
Why?
| | CD40 Ligand | 1 | 2018 | 42 | 0.040 |
Why?
| | Urinalysis | 1 | 2018 | 62 | 0.040 |
Why?
| | Papio | 1 | 2018 | 96 | 0.040 |
Why?
| | Sarcopenia | 1 | 2019 | 68 | 0.040 |
Why?
| | CTLA-4 Antigen | 1 | 2018 | 78 | 0.040 |
Why?
| | Renal Dialysis | 1 | 2021 | 371 | 0.040 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 188 | 0.040 |
Why?
| | Adenine | 1 | 2019 | 221 | 0.040 |
Why?
| | Climate Change | 1 | 2019 | 127 | 0.040 |
Why?
| | Animals, Genetically Modified | 1 | 2018 | 215 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2020 | 1059 | 0.040 |
Why?
| | Adenosine Triphosphate | 1 | 2019 | 430 | 0.040 |
Why?
| | Water Deprivation | 1 | 2016 | 8 | 0.040 |
Why?
| | Osmolar Concentration | 1 | 2017 | 178 | 0.030 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 143 | 0.030 |
Why?
| | Lipocalin-2 | 1 | 2016 | 62 | 0.030 |
Why?
| | Time Factors | 2 | 2017 | 6186 | 0.030 |
Why?
| | Age Distribution | 1 | 2017 | 341 | 0.030 |
Why?
| | Sex Distribution | 1 | 2017 | 338 | 0.030 |
Why?
| | Aged, 80 and over | 2 | 2017 | 6438 | 0.030 |
Why?
| | Swine | 1 | 2018 | 706 | 0.030 |
Why?
| | Nitric Oxide Synthase Type III | 1 | 2016 | 185 | 0.030 |
Why?
| | Creatinine | 1 | 2016 | 431 | 0.030 |
Why?
| | Linear Models | 1 | 2017 | 778 | 0.030 |
Why?
| | Kidney Cortex | 1 | 2014 | 23 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 794 | 0.030 |
Why?
| | Urate Oxidase | 1 | 2014 | 9 | 0.030 |
Why?
| | Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2014 | 15 | 0.030 |
Why?
| | Glucose-6-Phosphatase | 1 | 2014 | 31 | 0.030 |
Why?
| | Specific Pathogen-Free Organisms | 1 | 2014 | 60 | 0.030 |
Why?
| | Rats | 2 | 2012 | 5035 | 0.030 |
Why?
| | History, Ancient | 1 | 2014 | 51 | 0.030 |
Why?
| | Immunoglobulin G | 1 | 2018 | 782 | 0.030 |
Why?
| | Cell Line, Transformed | 1 | 2014 | 133 | 0.030 |
Why?
| | Mechanistic Target of Rapamycin Complex 2 | 1 | 2014 | 57 | 0.030 |
Why?
| | Transduction, Genetic | 1 | 2014 | 121 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2016 | 1226 | 0.030 |
Why?
| | Sciuridae | 1 | 2015 | 142 | 0.030 |
Why?
| | Hominidae | 1 | 2014 | 80 | 0.030 |
Why?
| | Europe | 1 | 2014 | 352 | 0.030 |
Why?
| | Phosphates | 1 | 2014 | 160 | 0.030 |
Why?
| | Cells, Cultured | 1 | 2020 | 3916 | 0.030 |
Why?
| | Carbon-Carbon Double Bond Isomerases | 1 | 2012 | 2 | 0.030 |
Why?
| | Chemokines | 1 | 2014 | 214 | 0.030 |
Why?
| | Fats | 1 | 2012 | 12 | 0.030 |
Why?
| | Survival Rate | 1 | 2017 | 1653 | 0.030 |
Why?
| | Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2012 | 24 | 0.030 |
Why?
| | Multiprotein Complexes | 1 | 2014 | 145 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2014 | 274 | 0.030 |
Why?
| | Allopurinol | 1 | 2012 | 55 | 0.030 |
Why?
| | Seasons | 1 | 2015 | 458 | 0.030 |
Why?
| | Comorbidity | 1 | 2017 | 1476 | 0.030 |
Why?
| | Databases, Factual | 1 | 2017 | 1149 | 0.030 |
Why?
| | Selection, Genetic | 1 | 2014 | 244 | 0.030 |
Why?
| | Fatty Acids | 1 | 2015 | 385 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2017 | 1817 | 0.030 |
Why?
| | Phosphorylation | 1 | 2016 | 1561 | 0.030 |
Why?
| | Lipid Metabolism | 1 | 2015 | 449 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2014 | 361 | 0.020 |
Why?
| | Recombinant Fusion Proteins | 1 | 2014 | 616 | 0.020 |
Why?
| | Disease Progression | 1 | 2017 | 2424 | 0.020 |
Why?
| | Transcriptional Activation | 1 | 2012 | 341 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2012 | 791 | 0.020 |
Why?
| | Prevalence | 1 | 2017 | 2270 | 0.020 |
Why?
| | Age Factors | 1 | 2017 | 2912 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2017 | 2437 | 0.020 |
Why?
| | Polymers | 1 | 2014 | 464 | 0.020 |
Why?
| | Glucose | 1 | 2015 | 904 | 0.020 |
Why?
| | Body Weight | 1 | 2014 | 872 | 0.020 |
Why?
| | Up-Regulation | 1 | 2012 | 824 | 0.020 |
Why?
| | Prognosis | 1 | 2017 | 3342 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2012 | 758 | 0.020 |
Why?
| | RNA, Messenger | 1 | 2016 | 2581 | 0.020 |
Why?
| | Metformin | 1 | 2012 | 278 | 0.020 |
Why?
| | Risk Assessment | 1 | 2017 | 3004 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2012 | 2262 | 0.020 |
Why?
| | Models, Biological | 1 | 2014 | 1647 | 0.020 |
Why?
| | Biomarkers | 1 | 2017 | 3474 | 0.020 |
Why?
| | Feeding Behavior | 1 | 2012 | 573 | 0.020 |
Why?
| | Cross-Sectional Studies | 1 | 2017 | 4449 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2014 | 1078 | 0.020 |
Why?
| | Blood Glucose | 1 | 2014 | 1826 | 0.020 |
Why?
| | Insulin | 1 | 2014 | 2083 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 17955 | 0.010 |
Why?
|
|
Garcia's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|